• Aggressive Surgery Increases Lung Cancer Patients’ Long-term Survival, Study Shows
  • ALCF, Boehringer Ingelheim Bring Gift of Volunteer Help to Lung Cancer Patients
  • Kalydeco Seen As Safe in Treating CF in Young Children, Ages 1 to 2, Study Data Show
  • Tecentriq Adds 38% to the Time It Takes for Lung Cancer to Progress, Trial Shows
  • Inhaled Thyroid Hormone May Work to Reverse Lung Fibrosis, Early Study Reports
  • Link Between Testosterone and Asthma Seen in Study, Likely Reason Women More Prone to This Disease
  • Former Football Player Helping CF Patients Obtain AffloVest Airway-clearing Devices
  • Veracyte Says Study Backs Up Usefulness of Envisia Genomic Classifier as IPF Diagnostic Tool
  • FDA Advisory Group Sets Jan. 11 Review Date for Linhaliq, Potential Non-CF Bronchiectasis Therapy
  • Restoring a DNA Repair Protein Reverses Lung Scarring, Mouse Study in Germany Shows
  • Skin Disease Atopic Dermatitis and Susceptibility to Allergies Increase Risk of Asthma, Study Finds
  • Boston and Toronto Researchers Discover Two Additional Molecules Involved in Lung Scarring

Pulmonary Fibrosis

Asthma

Bronchiectasis

BRONCHIOLITIS

CHRONIC BRONCHITIS

COPD

 CYSTIC FIBROSIS

EMPHYSEMA

IDIOPATHIC PULMONARY FIBROSIS

LUNG CANCER

PNEUMONIA

PULMONARY HYPERTENSION

SCLERODERMA